Table 5 Demographics of the human postmortem cases included in this study.
Case ID | Sex (m/f) | Age at diagnosis (y) | Age at death (y) | Disease duration (y) | Postmortem delay (h) | Braak stage (LB-type pathology) | Braak stage (AD-type pathology) |
|---|---|---|---|---|---|---|---|
PD1 | f | 65 | 86 | 21.0 | 78.4 | 6 | 1 |
PD2 | m | 55 | 75 | 20.0 | 88.5 | 6 | 1 |
PD3 | m | 60 | 84 | 24.0 | 71.0 | 6 | 2 |
PD4 | m | 62 | 80 | 18.5 | 67.0 | 6 | 3 |
PD5 | m | 68 | 80 | 11.9 | 100.0 | 6 | 2 |
PD6 | f | 61 | 81 | 20.0 | 135.0 | 6 | 2 |
PD7 | m | 80 | 89 | 8.5 | 26.0 | 6 | 4 |
PDD1 | m | 77 | 92 | 14.0 | 41.0 | 6 | 3 |
PDD2 | m | 61 | 80 | 19.0 | 66.0 | 6 | 2 |
DLB1 | f | 78 | 89 | 11.4 | 63.0 | 6 | 3 |
SNCA G51D1 | m | 19 | 49 | 30.0 | 43.0 | na | na |
SNCA G51D2 | f | 69 | 75 | 6.5 | 62.0 | na | 1 |
SNCA G51D3 | m | 45 | 52 | 6.5 | 85.3 | na | 1 |
SNCA H50Q1 | f | 70 | 83 | 12.5 | na | na | na |
SNCA duplication1 | m | 55 | 62 | 6.9 | 143.0 | 6 | 2 |
AD1 | m | 54 | 64 | 9.8 | 95.5 | 0 | 6 |
AD2 | f | 48 | 64 | 16.6 | 70.0 | na | 6 |
PiD1 | m | 55 | 71 | 16.4 | 51.0 | 0 | 0 |
PiD2 | m | 52 | 65 | 13.5 | 48.0 | 0 | 0 |
FTLD-TDP/C1 | f | 51 | 65 | 14.0 | 22.0 | 0 | 0 |
FTLD-TDP/C2 | m | 53 | 71 | 17.3 | 54.0 | 0 | 0 |
PSP1 | f | 74 | 79 | 6.3 | 105.0 | 0 | 2 |
PSP2 | m | 68 | 75 | 7.0 | 57.0 | 0 | 2 |
CBD1 | m | 51 | 60 | 9.0 | 40.0 | na | 0 |
CBD2 | m | 60 | 65 | 5.0 | 50.0 | 0 | 2 |
CTR1 | f | 67 | 84 | 16.0 | 40.0 | 0 | 2 |
CTR2 | m | 63 | 80 | 16.6 | 11.0 | 0 | 2 |
CTR3 | f | na | 89 | na | 24 | 0 | 2 |
CTR4 | m | na | 80 | na | 48 | 0 | 2 |
